HomeSciencePipeline

Cell Therapy for Cardiovascular Disease using Endothelial Cell
Substrate
Indication
Discovery
Pre-clinical
Phase 1
Phase 2
iPSC-EC
PAD
CAD
51%
38%
iPSC-EC/PA-RGDS
PAD
CAD
26%
38%
rEC (+/- PA-RGDS)
PAD
CAD
31%
31%

Innovative Cell Therapy for Cardiovascular Disease

More About Karis Bio
https://i0.wp.com/karisbio.com/wp-content/uploads/2021/09/Logo-KarisBio-18.png?fit=140%2C51&ssl=1
+82 2-363-0890
karisbio@karisbio.com
50-1 Yonsei-Ro, Seoul, Korea
543 Seongsan-ro, Seoul, Korea

Terms of Use

Privacy Policy

© 2021 KARIS BIO INC. ALL RIGHTS RESERVED

About

Science

News